02Cervavac receives WHO prequalification
Serum Institute announced on October 5 that its quadrivalent HPV vaccine Cervavac has received WHO prequalification. The vaccine targets HPV types 6, 11, 16 and 18 and is indicated for girls and boys aged 9-26. Prequalification permits procurement by UN agencies.
Useful?